Marrow stromal cells differentiate into vasculature after allogeneic transplantation into ischemic myocardium.

[1]  Pamela S. Vincent,et al.  Direct injection of autologous mesenchymal stromal cells improves myocardial function. , 2009, Biochemical and biophysical research communications.

[2]  Joshua M Hare,et al.  A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. , 2009, Journal of the American College of Cardiology.

[3]  Rongfeng Li,et al.  Method of oocyte activation affects cloning efficiency in pigs , 2009, Molecular reproduction and development.

[4]  W. Brenner,et al.  Pilot Trial on Determinants of Progenitor Cell Recruitment to the Infarcted Human Myocardium , 2008, Circulation.

[5]  J. Kastrup,et al.  Stem cell mobilization by granulocyte colony-stimulating factor for myocardial recovery after acute myocardial infarction: a meta-analysis. , 2008, Journal of the American College of Cardiology.

[6]  P. Bianco,et al.  Mesenchymal stem cells: revisiting history, concepts, and assays. , 2008, Cell stem cell.

[7]  Yuejin Yang,et al.  Effectiveness and tolerability of administration of granulocyte colony-stimulating factor on left ventricular function in patients with myocardial infarction: a meta-analysis of randomized controlled trials. , 2007, Clinical therapeutics.

[8]  J. Kastrup,et al.  Bone Marrow–Derived Mesenchymal Cell Mobilization by Granulocyte-Colony Stimulating Factor After Acute Myocardial Infarction: Results From the Stem Cells in Myocardial Infarction (STEMMI) Trial , 2007, Circulation.

[9]  Florian Tögel,et al.  Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. , 2007, American journal of physiology. Renal physiology.

[10]  A. Kastrati,et al.  Stem cell mobilization by granulocyte-colony-stimulating factor in acute myocardial infarction: lessons from the REVIVAL-2 trial , 2007, Nature Clinical Practice Cardiovascular Medicine.

[11]  K. Chien.  Lost and found: cardiac stem cell therapy revisited. , 2006, The Journal of clinical investigation.

[12]  Amit N. Patel,et al.  Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: a prospective randomized study. , 2005, The Journal of thoracic and cardiovascular surgery.

[13]  C. Nienaber,et al.  Preservation From Left Ventricular Remodeling by Front-Integrated Revascularization and Stem Cell Liberation in Evolving Acute Myocardial Infarction by Use of Granulocyte-Colony–Stimulating Factor (FIRSTLINE-AMI) , 2005, Circulation.

[14]  P. Wernet,et al.  Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease: the IACT Study. , 2005, Journal of the American College of Cardiology.

[15]  H. Rabb.  Paracrine and differentiation mechanisms underlying stem cell therapy for the damaged kidney. , 2005, American journal of physiology. Renal physiology.

[16]  Fei Ye,et al.  Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. , 2004, The American journal of cardiology.

[17]  H. Kang,et al.  Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomized clinical trial , 2004 .

[18]  Hyun-Jai Cho,et al.  Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial , 2004, The Lancet.

[19]  A. Zeiher,et al.  Infarct Remodeling After Intracoronary Progenitor Cell Treatment in Patients With Acute Myocardial Infarction (TOPCARE-AMI): Mechanistic Insights From Serial Contrast-Enhanced Magnetic Resonance Imaging , 2003, Circulation.

[20]  M. Cerqueira,et al.  Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease: a feasibility study. , 2003, Journal of the American College of Cardiology.

[21]  James T. Willerson,et al.  Transendocardial, Autologous Bone Marrow Cell Transplantation for Severe, Chronic Ischemic Heart Failure , 2003, Circulation.

[22]  P. Wernet,et al.  Repair of Infarcted Myocardium by Autologous Intracoronary Mononuclear Bone Marrow Cell Transplantation in Humans , 2002, Circulation.

[23]  N. Weissman,et al.  Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. , 2001, Journal of the American College of Cardiology.

[24]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[25]  Takayuki Asahara,et al.  Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.

[26]  M. Cheitlin,et al.  The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) Trial: First Randomized Placebo-Controlled Study of Myoblast Transplantation , 2009 .

[27]  A. Zeiher,et al.  ransplantation of Progenitor Cells nd Regeneration Enhancement n Acute Myocardial Infarction , 2004 .